Financhill
Back

Abbott Laboratories Quote, Financials, Valuation and Earnings

Abbott Laboratories Price Quote

$109.97
+0.02 (+-0.99%)
(Updated: January 28, 2023 at 4:14 AM ET)

Abbott Laboratories Key Stats

Sell
47
Abbott Laboratories (ABT) is a Sell

Day range:
$109.81 - $111.26
52-week range:
$93.25 - $130.94
Dividend yield:
1.75%
P/E ratio:
28.13
P/S ratio:
4.44
P/B ratio:
5.37%

Volume:
4.9M
Avg. volume:
4.7M
1-year change:
-8.71%
Market cap:
$191.7B
Revenue:
$43.7B
EPS:
$3.91

How Much Does Abbott Laboratories Make?

Is Abbott Laboratories Growing As A Company?

  • What Is Abbott Laboratories's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.12%
  • What Is Abbott Laboratories's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.47%

Abbott Laboratories Stock Price Performance

What Is Abbott Laboratories 52-Week High & Low?

Abbott Laboratories Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Abbott Laboratories?

Is Abbott Laboratories Cash Flow Positive?

  • What Is ABT Cash Flow From Operations?
    Cash flow from operations (TTM) is $10.3B
  • What Is Abbott Laboratories’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$8.1B
  • What Is Abbott Laboratories’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.8B

Abbott Laboratories Return On Invested Capital

  • Is Management Doing A Good Job?
    ABT return on invested capital is 13.05%
  • What Is Abbott Laboratories Return On Assets?
    ROA measures how assets are converting to revenues and is 9.36%
  • What Is ABT Return On Equity?
    ROE is a measure of profitability and is 22.19%

Abbott Laboratories Earnings Date & Stock Price

Abbott Laboratories Competitors

  • Who Are Abbott Laboratories's Competitors?
    Below is a list of companies who compete with Abbott Laboratories or are related in some way:
    • Baxter International Inc (BAX)
    • Becton, Dickinson and Co (BDX)
    • Intuitive Surgical Inc (ISRG)
    • ShockWave Medical Inc (SWAV)
    • Stryker Corp (SYK)

Abbott Laboratories Dividend Yield

Abbott Laboratories Analyst Estimates

YoY Growth Past Surprise
EPS: -46.85% 10.64%
Revenue: -12.01% 3.96%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 5
Sell Recommendations: 1
Price Target: 120.97
Upside from Last Price: 10.02%

Major Shareholders

  • How many ABT shares are owned by institutional investors?
    2.3B ABT shares are owned by institutional investors
  • How many ABT shares are owned by insiders?
    15M ABT shares are owned by insiders